<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TOLMETIN SODIUM</span><br/>(tole'met-in)<br/><span class="topboxtradename">Tolectin, </span><span class="topboxtradename">Tolectin DS<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">analgesic</span>; <span class="classification">nsaid</span>; <span class="classification">antipyretic</span><br/><b>Prototype: </b>Ibuprofen<br/><b>Pregnancy Category: </b> B  (D in third trimester)<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>200 mg, 600 mg tablets; 400 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>Related to indomethacin. Exact mode of antiinflammatory action not known. Inhibition of platelet aggregation is less than
         that produced by equal therapeutic doses of aspirin. Comparable to aspirin and indomethacin in antirheumatic activity, but
         incidence of GI symptoms and tinnitus is less than in aspirin-treated patients, and CNS effects are less than in patients
         receiving indomethacin.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Possesses analgesic, antiinflammatory, and antipyretic activity.</p>
<h1><a name="uses">Uses</a></h1>
<p>In acute flares and management of chronic rheumatoid arthritis. May be used alone or in combination with gold or corticosteroids.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>History of intolerance or hypersensitivity to tolmetin, aspirin, and other <small>NSAID</small>s; active peptic ulcer, patients with asthma, nasal polyps, rhinitis, "aspirin triad," in patients with functional
         class IV rheumatoid arthritis (severely incapacitated, bedridden, or confined to a wheelchair). Safety during pregnancy (category
         B, category D in third trimester), lactation, or children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>History of upper GI tract disease; impaired kidney function; compromised cardiac function.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Arthritis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 400 mg t.i.d. (max: 2 g/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> <img src="../images/special/greaterorequal.gif"/><i>2 y</i>, 20 mg/kg/d in 34 divided doses (max: 30 mg/kg/d)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Schedule treatment (preferred) to include a morning dose (on arising) and a bedtime dose.</li>
<li>Give with fluid of patient's choice; crush tablet or empty capsule to mix with water or food if patient cannot swallow tablet/capsule.</li>
<li>Store at 15°30° C (59°86° F) in tightly capped and light-resistant container unless otherwise
            instructed.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span>
<span class="speceff-common">Headache, dizziness, vertigo, lightheadedness,</span> mood elevation or depression, tension, nervousness, weakness, drowsiness, insomnia, tinnitus. <span class="typehead">CV:</span> Mild edema (about 7% patients), sodium and water retention, mild to moderate hypertension. <span class="typehead">GI:</span> Epigastric or abdominal pain, dyspepsia, <span class="speceff-common">nausea,</span> vomiting, heartburn, constipation, peptic ulcer, <span class="speceff-life">GI bleeding</span>. <span class="typehead">Hematologic:</span> Transient and small decreases in hemoglobin and hematocrit, purpura, petechiae, granulocytopenia, leukopenia. <span class="typehead">Urogenital:</span> Hematuria, proteinuria, increased BUN. <span class="typehead">Skin:</span>
<span class="speceff-life">Toxic epidermal necrolysis</span>, morbilliform eruptions, urticaria, pruritus. <span class="typehead">Body as a Whole:</span>
<span class="speceff-life">Anaphylaxis</span> (especially after drug is discontinued and then reinstituted). 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Tolmetin prolongs <span class="alt">bleeding time,</span> inhibits <span class="alt">platelet aggregation,</span> elevates <span class="alt">BUN,</span>
<span class="alt">alkaline phosphatase,</span> and <span class="alt">AST</span> levels; may decrease <span class="alt">hemoglobin</span> and <span class="alt">hematocrit</span> values. Metabolites may produce false-positive results for <span class="alt">proteinuria</span> (with tests that rely on acid precipitation, e.g., <span class="alt">sulfosalicylic acid</span>).
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">oral anticoagulants</span>, <b>heparin</b> may prolong bleeding time; may increase <b>lithium</b> toxicity; <b>aspirin,</b> other <span class="classification">nsaid</span>s add to ulcerogenic effects; may increase <b>methotrexate</b> toxicity. <span class="typehead">Herbal:</span>
<b>Feverfew,</b>
<b>garlic,</b>
<b>ginger,</b>
<b>ginkgo</b> may increase bleeding potential. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract. <span class="typehead">Peak:</span>  3060 min. <span class="typehead"> Distribution:</span> Crosses bloodbrain barrier and placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 6090 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor therapeutic effect. Therapeutic response for rheumatoid arthritis or osteoarthritis generally occurs within 1 wk with
            progressive improvement in succeeding week: Reduced joint pain and swelling, reduction in duration of morning stiffness, improved
            functional capacity (increase in grip strength, delayed onset of fatigue).
         </li>
<li>Monitor patients with kidney damage closely. Evaluate I&amp;O ratio and encourage patient to increase fluid intake to at least
            8 full glasses per day.
         </li>
<li>Lab tests: Obtain periodic kidney function tests (routine urinalysis, creatinine clearance, and serum creatinine) for patient
            on long-term therapy.
         </li>
<li>Check self-medicating habits of the patient. Sodium bicarbonate alkalinizes the urine, which increases urinary excretion of
            tolmetin and may reduce degree and duration of effectiveness.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take drug with meals or milk if GI disturbances occur. Notify physician if symptoms persist; dosage reduction may be necessary,
            or antacid added.
         </li>
<li>Monitor weight and report an increase &gt;2 kg (4 lb)/wk with impaired kidney or cardiac function; check for swelling in ankles,
            tibiae, hands, and feet.
         </li>
<li>Inform surgeon or dentist before treatment if you are taking tolmetin because of possible enhanced bleeding.</li>
<li>Report promptly signs of abnormal bleeding (ecchymosis, epistaxis, melena, petechiae), itching, skin rash, persistent headache,
            edema.
         </li>
<li>Avoid potentially hazardous activities until response to drug is known because dizziness and drowsiness are common adverse
            effects.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>